UniProt ID | IFIH1_MOUSE | |
---|---|---|
UniProt AC | Q8R5F7 | |
Protein Name | Interferon-induced helicase C domain-containing protein 1 | |
Gene Name | Ifih1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1025 | |
Subcellular Localization | Cytoplasm . Nucleus . May be found in the nucleus, during apoptosis. | |
Protein Description | Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines. Its ligands include mRNA lacking 2'-O-methylation at their 5' cap and long-dsRNA (>1 kb in length). Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Responsible for detecting the Picornaviridae family members such as encephalomyocarditis virus (EMCV), mengo encephalomyocarditis virus (ENMG), and theiler's murine encephalomyelitis virus (TMEV). Can also detect other viruses such as dengue virus (DENV), west Nile virus (WNV), and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome, such as vaccinia virus. Plays an important role in amplifying innate immune signaling through recognition of RNA metabolites that are produced during virus infection by ribonuclease L (RNase L). May play an important role in enhancing natural killer cell function and may be involved in growth inhibition and apoptosis in several tumor cell lines.. | |
Protein Sequence | MSIVCSAEDSFRNLILFFRPRLKMYIQVEPVLDHLIFLSAETKEQILKKINTCGNTSAAELLLSTLEQGQWPLGWTQMFVEALEHSGNPLAARYVKPTLTDLPSPSSETAHDECLHLLTLLQPTLVDKLLINDVLDTCFEKGLLTVEDRNRISAAGNSGNESGVRELLRRIVQKENWFSTFLDVLRQTGNDALFQELTGGGCPEDNTDLANSSHRDGPAANECLLPAVDESSLETEAWNVDDILPEASCTDSSVTTESDTSLAEGSVSCFDESLGHNSNMGRDSGTMGSDSDESVIQTKRVSPEPELQLRPYQMEVAQPALDGKNIIICLPTGSGKTRVAVYITKDHLDKKKQASESGKVIVLVNKVMLAEQLFRKEFNPYLKKWYRIIGLSGDTQLKISFPEVVKSYDVIISTAQILENSLLNLESGDDDGVQLSDFSLIIIDECHHTNKEAVYNNIMRRYLKQKLRNNDLKKQNKPAIPLPQILGLTASPGVGAAKKQSEAEKHILNICANLDAFTIKTVKENLGQLKHQIKEPCKKFVIADDTRENPFKEKLLEIMASIQTYCQKSPMSDFGTQHYEQWAIQMEKKAAKDGNRKDRVCAEHLRKYNEALQINDTIRMIDAYSHLETFYTDEKEKKFAVLNDSDKSDDEASSCNDQLKGDVKKSLKLDETDEFLMNLFFDNKKMLKKLAENPKYENEKLIKLRNTILEQFTRSEESSRGIIFTKTRQSTYALSQWIMENAKFAEVGVKAHHLIGAGHSSEVKPMTQTEQKEVISKFRTGEINLLIATTVAEEGLDIKECNIVIRYGLVTNEIAMVQARGRARADESTYVLVTSSGSGVTEREIVNDFREKMMYKAINRVQNMKPEEYAHKILELQVQSILEKKMKVKRSIAKQYNDNPSLITLLCKNCSMLVCSGENIHVIEKMHHVNMTPEFKGLYIVRENKALQKKFADYQTNGEIICKCGQAWGTMMVHKGLDLPCLKIRNFVVNFKNNSPKKQYKKWVELPIRFPDLDYSEYCLYSDED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
94 | Phosphorylation | GNPLAARYVKPTLTD CCCHHHHHCCCCCCC | 14.22 | 23984901 | |
98 | Phosphorylation | AARYVKPTLTDLPSP HHHHCCCCCCCCCCC | 36.25 | 23649490 | |
100 | Phosphorylation | RYVKPTLTDLPSPSS HHCCCCCCCCCCCCC | 37.66 | 23984901 | |
104 | Phosphorylation | PTLTDLPSPSSETAH CCCCCCCCCCCCCHH | 44.72 | 23984901 | |
106 | Phosphorylation | LTDLPSPSSETAHDE CCCCCCCCCCCHHHH | 45.18 | 23984901 | |
107 | Phosphorylation | TDLPSPSSETAHDEC CCCCCCCCCCHHHHH | 42.21 | 23649490 | |
109 | Phosphorylation | LPSPSSETAHDECLH CCCCCCCCHHHHHHH | 31.10 | 23984901 | |
119 | Phosphorylation | DECLHLLTLLQPTLV HHHHHHHHHHCHHHH | 31.61 | 23984901 | |
124 | Phosphorylation | LLTLLQPTLVDKLLI HHHHHCHHHHHHHHH | 26.84 | 23984901 | |
284 | Phosphorylation | NSNMGRDSGTMGSDS CCCCCCCCCCCCCCC | 34.50 | 23684622 | |
286 | Phosphorylation | NMGRDSGTMGSDSDE CCCCCCCCCCCCCCC | 23.47 | 25521595 | |
289 | Phosphorylation | RDSGTMGSDSDESVI CCCCCCCCCCCCCHH | 24.10 | 25521595 | |
291 | Phosphorylation | SGTMGSDSDESVIQT CCCCCCCCCCCHHCC | 45.00 | 25521595 | |
294 | Phosphorylation | MGSDSDESVIQTKRV CCCCCCCCHHCCCCC | 29.52 | 27742792 | |
298 | Phosphorylation | SDESVIQTKRVSPEP CCCCHHCCCCCCCCC | 15.08 | 28833060 | |
302 | Phosphorylation | VIQTKRVSPEPELQL HHCCCCCCCCCCCCC | 27.81 | 25521595 | |
312 | Phosphorylation | PELQLRPYQMEVAQP CCCCCCCEECCCCCC | 17.66 | 28833060 | |
334 | Phosphorylation | IICLPTGSGKTRVAV EEEEECCCCCEEEEE | 39.33 | 27357545 | |
392 | Phosphorylation | WYRIIGLSGDTQLKI HHHHCCCCCCCEEEE | 29.43 | - | |
395 | Phosphorylation | IIGLSGDTQLKISFP HCCCCCCCEEEEEHH | 39.05 | - | |
477 | Ubiquitination | NDLKKQNKPAIPLPQ CCHHHCCCCCCCHHH | 33.08 | - | |
523 | Ubiquitination | AFTIKTVKENLGQLK CCCHHHHHHHHHHHH | 46.23 | - | |
539 | Malonylation | QIKEPCKKFVIADDT HCCCCCCCEEECCCC | 52.13 | 26320211 | |
569 | Phosphorylation | IQTYCQKSPMSDFGT HHHHHHHCCCCCCCH | 10.43 | 22802335 | |
572 | Phosphorylation | YCQKSPMSDFGTQHY HHHHCCCCCCCHHHH | 32.92 | 22802335 | |
576 | Phosphorylation | SPMSDFGTQHYEQWA CCCCCCCHHHHHHHH | 16.50 | 22802335 | |
579 | Phosphorylation | SDFGTQHYEQWAIQM CCCCHHHHHHHHHHH | 10.45 | 22802335 | |
645 | Phosphorylation | KFAVLNDSDKSDDEA EEEECCCCCCCCHHH | 45.95 | 25521595 | |
648 | Phosphorylation | VLNDSDKSDDEASSC ECCCCCCCCHHHHHC | 56.11 | 25521595 | |
653 | Phosphorylation | DKSDDEASSCNDQLK CCCCHHHHHCHHHHC | 33.12 | 22324799 | |
654 | Phosphorylation | KSDDEASSCNDQLKG CCCHHHHHCHHHHCC | 24.80 | 25266776 | |
695 | Succinylation | KKLAENPKYENEKLI HHHHHCCCCCCHHHH | 76.43 | 23954790 | |
828 | Phosphorylation | GRARADESTYVLVTS CCCCCCCCCEEEEEC | 26.11 | 30635358 | |
829 | Phosphorylation | RARADESTYVLVTSS CCCCCCCCEEEEECC | 18.66 | 30635358 | |
830 | Phosphorylation | ARADESTYVLVTSSG CCCCCCCEEEEECCC | 10.89 | 30635358 | |
834 | Phosphorylation | ESTYVLVTSSGSGVT CCCEEEEECCCCCCC | 17.02 | 30635358 | |
835 | Phosphorylation | STYVLVTSSGSGVTE CCEEEEECCCCCCCH | 25.81 | 30635358 | |
836 | Phosphorylation | TYVLVTSSGSGVTER CEEEEECCCCCCCHH | 27.84 | 30635358 | |
838 | Phosphorylation | VLVTSSGSGVTEREI EEEECCCCCCCHHHH | 31.85 | 30635358 | |
841 | Phosphorylation | TSSGSGVTEREIVND ECCCCCCCHHHHHHH | 32.61 | 30635358 | |
896 | Phosphorylation | KRSIAKQYNDNPSLI HHHHHHHCCCCHHHH | 24.63 | 22871156 | |
904 | Phosphorylation | NDNPSLITLLCKNCS CCCHHHHHHHCCCCC | 20.97 | 22871156 | |
950 | Ubiquitination | ENKALQKKFADYQTN CCHHHHHHHCCCCCC | 32.59 | - | |
983 | Ubiquitination | GLDLPCLKIRNFVVN CCCCCEEEEEEEEEE | 46.46 | - | |
1021 | Phosphorylation | DYSEYCLYSDED--- CHHHHEEECCCC--- | 15.54 | 29550500 | |
1022 | Phosphorylation | YSEYCLYSDED---- HHHHEEECCCC---- | 22.90 | 26643407 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
828 | S | Phosphorylation | Kinase | RIOK3 | Q9DBU3 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IFIH1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IFIH1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-302; SER-645 ANDSER-648, AND MASS SPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289, AND MASSSPECTROMETRY. |